Chronic Graft Versus Host Disease

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

Improving Outcomes Assessment in Chronic GVHD

Upfront Ruxolitinib for Chronic Graft-vs-host Disease